Intravenous (IV) Solutions Market, Global Outlook and Forecast 2022-2028

March 2022 | 64 pages | ID: IF548B69C93DEN
Market Monitor Global

Abstracts

Intravenous (IV) solutions are fluids which are intended to be administered to a patient directly into the venous circulation.

This report contains market size and forecasts of Intravenous (IV) Solutions in Global, including the following market information:

Global Intravenous (IV) Solutions Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Intravenous (IV) Solutions market was valued at 7922.8 million in 2021 and is projected to reach US$ 10550 million by 2028, at a CAGR of 4.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Peripheral Parenteral Nutrition Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Intravenous (IV) Solutions include ICU Medical Inc. (U.S.), B. Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), Baxter (U.S.), Amanta Healthcare (India), Terumo Medical Corporation (Tokyo) and Grifols S.A. (Spain), etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Intravenous (IV) Solutions companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Intravenous (IV) Solutions Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Intravenous (IV) Solutions Market Segment Percentages, by Type, 2021 (%)

• Peripheral Parenteral Nutrition
• Total Parenteral Nutrition

Global Intravenous (IV) Solutions Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Intravenous (IV) Solutions Market Segment Percentages, by Application, 2021 (%)

• Hospital & Clinics
• Ambulatory
• Home Care

Global Intravenous (IV) Solutions Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Intravenous (IV) Solutions Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Intravenous (IV) Solutions revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Intravenous (IV) Solutions revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• ICU Medical Inc. (U.S.)
• B. Braun Melsungen AG (Germany)
• Fresenius Kabi AG (Germany)
• Baxter (U.S.)
• Amanta Healthcare (India)
• Terumo Medical Corporation (Tokyo)
• Grifols S.A. (Spain)

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Intravenous (IV) Solutions Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Intravenous (IV) Solutions Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL INTRAVENOUS (IV) SOLUTIONS OVERALL MARKET SIZE

2.1 Global Intravenous (IV) Solutions Market Size: 2021 VS 2028
2.2 Global Intravenous (IV) Solutions Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Intravenous (IV) Solutions Players in Global Market
3.2 Top Global Intravenous (IV) Solutions Companies Ranked by Revenue
3.3 Global Intravenous (IV) Solutions Revenue by Companies
3.4 Top 3 and Top 5 Intravenous (IV) Solutions Companies in Global Market, by Revenue in 2021
3.5 Global Companies Intravenous (IV) Solutions Product Type
3.6 Tier 1, Tier 2 and Tier 3 Intravenous (IV) Solutions Players in Global Market
  3.6.1 List of Global Tier 1 Intravenous (IV) Solutions Companies
  3.6.2 List of Global Tier 2 and Tier 3 Intravenous (IV) Solutions Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Intravenous (IV) Solutions Market Size Markets, 2021 & 2028
  4.1.2 Peripheral Parenteral Nutrition
  4.1.3 Total Parenteral Nutrition
4.2 By Type - Global Intravenous (IV) Solutions Revenue & Forecasts
  4.2.1 By Type - Global Intravenous (IV) Solutions Revenue, 2017-2022
  4.2.2 By Type - Global Intravenous (IV) Solutions Revenue, 2023-2028
  4.2.3 By Type - Global Intravenous (IV) Solutions Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Intravenous (IV) Solutions Market Size, 2021 & 2028
  5.1.2 Hospital & Clinics
  5.1.3 Ambulatory
  5.1.4 Home Care
5.2 By Application - Global Intravenous (IV) Solutions Revenue & Forecasts
  5.2.1 By Application - Global Intravenous (IV) Solutions Revenue, 2017-2022
  5.2.2 By Application - Global Intravenous (IV) Solutions Revenue, 2023-2028
  5.2.3 By Application - Global Intravenous (IV) Solutions Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Intravenous (IV) Solutions Market Size, 2021 & 2028
6.2 By Region - Global Intravenous (IV) Solutions Revenue & Forecasts
  6.2.1 By Region - Global Intravenous (IV) Solutions Revenue, 2017-2022
  6.2.2 By Region - Global Intravenous (IV) Solutions Revenue, 2023-2028
  6.2.3 By Region - Global Intravenous (IV) Solutions Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Intravenous (IV) Solutions Revenue, 2017-2028
  6.3.2 US Intravenous (IV) Solutions Market Size, 2017-2028
  6.3.3 Canada Intravenous (IV) Solutions Market Size, 2017-2028
  6.3.4 Mexico Intravenous (IV) Solutions Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Intravenous (IV) Solutions Revenue, 2017-2028
  6.4.2 Germany Intravenous (IV) Solutions Market Size, 2017-2028
  6.4.3 France Intravenous (IV) Solutions Market Size, 2017-2028
  6.4.4 U.K. Intravenous (IV) Solutions Market Size, 2017-2028
  6.4.5 Italy Intravenous (IV) Solutions Market Size, 2017-2028
  6.4.6 Russia Intravenous (IV) Solutions Market Size, 2017-2028
  6.4.7 Nordic Countries Intravenous (IV) Solutions Market Size, 2017-2028
  6.4.8 Benelux Intravenous (IV) Solutions Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Intravenous (IV) Solutions Revenue, 2017-2028
  6.5.2 China Intravenous (IV) Solutions Market Size, 2017-2028
  6.5.3 Japan Intravenous (IV) Solutions Market Size, 2017-2028
  6.5.4 South Korea Intravenous (IV) Solutions Market Size, 2017-2028
  6.5.5 Southeast Asia Intravenous (IV) Solutions Market Size, 2017-2028
  6.5.6 India Intravenous (IV) Solutions Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Intravenous (IV) Solutions Revenue, 2017-2028
  6.6.2 Brazil Intravenous (IV) Solutions Market Size, 2017-2028
  6.6.3 Argentina Intravenous (IV) Solutions Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Intravenous (IV) Solutions Revenue, 2017-2028
  6.7.2 Turkey Intravenous (IV) Solutions Market Size, 2017-2028
  6.7.3 Israel Intravenous (IV) Solutions Market Size, 2017-2028
  6.7.4 Saudi Arabia Intravenous (IV) Solutions Market Size, 2017-2028
  6.7.5 UAE Intravenous (IV) Solutions Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 ICU Medical Inc. (U.S.)
  7.1.1 ICU Medical Inc. (U.S.) Corporate Summary
  7.1.2 ICU Medical Inc. (U.S.) Business Overview
  7.1.3 ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Major Product Offerings
  7.1.4 ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Revenue in Global Market (2017-2022)
  7.1.5 ICU Medical Inc. (U.S.) Key News
7.2 B. Braun Melsungen AG (Germany)
  7.2.1 B. Braun Melsungen AG (Germany) Corporate Summary
  7.2.2 B. Braun Melsungen AG (Germany) Business Overview
  7.2.3 B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Major Product Offerings
  7.2.4 B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Revenue in Global Market (2017-2022)
  7.2.5 B. Braun Melsungen AG (Germany) Key News
7.3 Fresenius Kabi AG (Germany)
  7.3.1 Fresenius Kabi AG (Germany) Corporate Summary
  7.3.2 Fresenius Kabi AG (Germany) Business Overview
  7.3.3 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Major Product Offerings
  7.3.4 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Revenue in Global Market (2017-2022)
  7.3.5 Fresenius Kabi AG (Germany) Key News
7.4 Baxter (U.S.)
  7.4.1 Baxter (U.S.) Corporate Summary
  7.4.2 Baxter (U.S.) Business Overview
  7.4.3 Baxter (U.S.) Intravenous (IV) Solutions Major Product Offerings
  7.4.4 Baxter (U.S.) Intravenous (IV) Solutions Revenue in Global Market (2017-2022)
  7.4.5 Baxter (U.S.) Key News
7.5 Amanta Healthcare (India)
  7.5.1 Amanta Healthcare (India) Corporate Summary
  7.5.2 Amanta Healthcare (India) Business Overview
  7.5.3 Amanta Healthcare (India) Intravenous (IV) Solutions Major Product Offerings
  7.5.4 Amanta Healthcare (India) Intravenous (IV) Solutions Revenue in Global Market (2017-2022)
  7.5.5 Amanta Healthcare (India) Key News
7.6 Terumo Medical Corporation (Tokyo)
  7.6.1 Terumo Medical Corporation (Tokyo) Corporate Summary
  7.6.2 Terumo Medical Corporation (Tokyo) Business Overview
  7.6.3 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Major Product Offerings
  7.6.4 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Revenue in Global Market (2017-2022)
  7.6.5 Terumo Medical Corporation (Tokyo) Key News
7.7 Grifols S.A. (Spain)
  7.7.1 Grifols S.A. (Spain) Corporate Summary
  7.7.2 Grifols S.A. (Spain) Business Overview
  7.7.3 Grifols S.A. (Spain) Intravenous (IV) Solutions Major Product Offerings
  7.7.4 Grifols S.A. (Spain) Intravenous (IV) Solutions Revenue in Global Market (2017-2022)
  7.7.5 Grifols S.A. (Spain) Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Intravenous (IV) Solutions Market Opportunities & Trends in Global Market
Table 2. Intravenous (IV) Solutions Market Drivers in Global Market
Table 3. Intravenous (IV) Solutions Market Restraints in Global Market
Table 4. Key Players of Intravenous (IV) Solutions in Global Market
Table 5. Top Intravenous (IV) Solutions Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Intravenous (IV) Solutions Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Intravenous (IV) Solutions Revenue Share by Companies, 2017-2022
Table 8. Global Companies Intravenous (IV) Solutions Product Type
Table 9. List of Global Tier 1 Intravenous (IV) Solutions Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Intravenous (IV) Solutions Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Intravenous (IV) Solutions Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Intravenous (IV) Solutions Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Intravenous (IV) Solutions Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Intravenous (IV) Solutions Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Intravenous (IV) Solutions Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Intravenous (IV) Solutions Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Intravenous (IV) Solutions Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Intravenous (IV) Solutions Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Intravenous (IV) Solutions Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Intravenous (IV) Solutions Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Intravenous (IV) Solutions Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Intravenous (IV) Solutions Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Intravenous (IV) Solutions Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Intravenous (IV) Solutions Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Intravenous (IV) Solutions Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Intravenous (IV) Solutions Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Intravenous (IV) Solutions Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Intravenous (IV) Solutions Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Intravenous (IV) Solutions Revenue, (US$, Mn), 2023-2028
Table 30. ICU Medical Inc. (U.S.) Corporate Summary
Table 31. ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Product Offerings
Table 32. ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Revenue (US$, Mn), (2017-2022)
Table 33. B. Braun Melsungen AG (Germany) Corporate Summary
Table 34. B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Product Offerings
Table 35. B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Revenue (US$, Mn), (2017-2022)
Table 36. Fresenius Kabi AG (Germany) Corporate Summary
Table 37. Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Product Offerings
Table 38. Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Revenue (US$, Mn), (2017-2022)
Table 39. Baxter (U.S.) Corporate Summary
Table 40. Baxter (U.S.) Intravenous (IV) Solutions Product Offerings
Table 41. Baxter (U.S.) Intravenous (IV) Solutions Revenue (US$, Mn), (2017-2022)
Table 42. Amanta Healthcare (India) Corporate Summary
Table 43. Amanta Healthcare (India) Intravenous (IV) Solutions Product Offerings
Table 44. Amanta Healthcare (India) Intravenous (IV) Solutions Revenue (US$, Mn), (2017-2022)
Table 45. Terumo Medical Corporation (Tokyo) Corporate Summary
Table 46. Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Product Offerings
Table 47. Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Revenue (US$, Mn), (2017-2022)
Table 48. Grifols S.A. (Spain) Corporate Summary
Table 49. Grifols S.A. (Spain) Intravenous (IV) Solutions Product Offerings
Table 50. Grifols S.A. (Spain) Intravenous (IV) Solutions Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Intravenous (IV) Solutions Segment by Type in 2021
Figure 2. Intravenous (IV) Solutions Segment by Application in 2021
Figure 3. Global Intravenous (IV) Solutions Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Intravenous (IV) Solutions Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Intravenous (IV) Solutions Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Intravenous (IV) Solutions Revenue in 2021
Figure 8. By Type - Global Intravenous (IV) Solutions Revenue Market Share, 2017-2028
Figure 9. By Application - Global Intravenous (IV) Solutions Revenue Market Share, 2017-2028
Figure 10. By Region - Global Intravenous (IV) Solutions Revenue Market Share, 2017-2028
Figure 11. By Country - North America Intravenous (IV) Solutions Revenue Market Share, 2017-2028
Figure 12. US Intravenous (IV) Solutions Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Intravenous (IV) Solutions Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Intravenous (IV) Solutions Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Intravenous (IV) Solutions Revenue Market Share, 2017-2028
Figure 16. Germany Intravenous (IV) Solutions Revenue, (US$, Mn), 2017-2028
Figure 17. France Intravenous (IV) Solutions Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Intravenous (IV) Solutions Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Intravenous (IV) Solutions Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Intravenous (IV) Solutions Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Intravenous (IV) Solutions Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Intravenous (IV) Solutions Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Intravenous (IV) Solutions Revenue Market Share, 2017-2028
Figure 24. China Intravenous (IV) Solutions Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Intravenous (IV) Solutions Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Intravenous (IV) Solutions Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Intravenous (IV) Solutions Revenue, (US$, Mn), 2017-2028
Figure 28. India Intravenous (IV) Solutions Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Intravenous (IV) Solutions Revenue Market Share, 2017-2028
Figure 30. Brazil Intravenous (IV) Solutions Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Intravenous (IV) Solutions Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Intravenous (IV) Solutions Revenue Market Share, 2017-2028
Figure 33. Turkey Intravenous (IV) Solutions Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Intravenous (IV) Solutions Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Intravenous (IV) Solutions Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Intravenous (IV) Solutions Revenue, (US$, Mn), 2017-2028
Figure 37. ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Baxter (U.S.) Intravenous (IV) Solutions Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Amanta Healthcare (India) Intravenous (IV) Solutions Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Grifols S.A. (Spain) Intravenous (IV) Solutions Revenue Year Over Year Growth (US$, Mn) & (2017-2022)